Hijiya, N. Et Al. 2023. The Long-term Efficacy and Safety of Nilotinib in Pediatric Patients With CML: a 5-Year Update of the DIALOG Study.. Blood advances .

Hijiya, N., Maschan, A., Rizzari, C., Shimada, H., Dufour, C., Goto, H., ... Kang, H. J.(2023). The Long-term Efficacy and Safety of Nilotinib in Pediatric Patients With CML: a 5-Year Update of the DIALOG Study.. Blood advances .

Hijiya, Nobuko Et Al. "The Long-term Efficacy and Safety of Nilotinib in Pediatric Patients With CML: a 5-Year Update of the DIALOG Study.," Blood advances , 2023

Hijiya, Nobuko Et Al. "The Long-term Efficacy and Safety of Nilotinib in Pediatric Patients With CML: a 5-Year Update of the DIALOG Study.." Blood advances , 2023

Hijiya, N. Et Al. (2023) . "The Long-term Efficacy and Safety of Nilotinib in Pediatric Patients With CML: a 5-Year Update of the DIALOG Study.." Blood advances .

@article{article, author={Nobuko Hijiya Et Al. }, title={The Long-term Efficacy and Safety of Nilotinib in Pediatric Patients With CML: a 5-Year Update of the DIALOG Study.}, journal={Blood advances}, year=2023}